Is it effective to initiate cilostazol-based dual antiplatelet therapy before achieving blood pressure control? Lessons from the CSPS study
- PMID: 39117951
- DOI: 10.1038/s41440-024-01813-5
Is it effective to initiate cilostazol-based dual antiplatelet therapy before achieving blood pressure control? Lessons from the CSPS study
Keywords: Antiplatelet therapy; Hypertension; Stroke.
Comment on
-
Blood pressure during long-term cilostazol-based dual antiplatelet therapy after stroke: a post hoc analysis of the CSPS.com trial.Hypertens Res. 2024 Sep;47(9):2238-2249. doi: 10.1038/s41440-024-01742-3. Epub 2024 Jul 9. Hypertens Res. 2024. PMID: 38977876 Free PMC article. Clinical Trial.
References
-
- Collaborators GBDS. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20:795–820. - DOI
-
- Group PC. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033–41. - DOI
-
- Whelton PK, Carey RM, Aronow WS, Casey DE Jr., Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:2199–269. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
